Proven efficacy and specialist studies on the Carci Reagent® test
The orientational home test Carci Reagent® is the result of extensive research and clinical testing. It was developed as an aid for the early detection of changes in tyrosine metabolism that may be linked to certain serious health conditions. Unlike many ordinary home tests, Carci Reagent® is based on a scientifically verified foundation with high sensitivity and specificity, making it a trustworthy companion in personal preventive care.
Clinically confirmed accuracy
As part of the clinical validation, more than 8,000 urine samples were analysed.
- in the group of patients with a confirmed malignant diagnosis (4,375 samples), the test was positive in 96.7% of cases,
- in the group of healthy individuals and patients with other diseases (3,703 samples), a positive result was found in only 3.35% of cases.
This corresponds to –
- a sensitivity of 96.7%,
- a specificity of 99.4%.
These results show that Carci Reagent® is highly reliable at detecting abnormalities that may be associated with the presence of tumour cells.
Links to scientific studies
- Evidence of abnormal tyrosine phosphorylated proteins in the urine of patients with bladder cancer: the road toward a new diagnostic tool?
- Correlation between stage of prostate cancer and tyrosine and tryptophan in urine samples measured electrochemically
- Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins
- Urinary tyrosine-phosphorylated proteins: a non-invasive marker for diagnosis, prognosis and follow-up for bladder cancer
- Tyrosine, Phenylalanine, and Tryptophan in Gastroesophageal Malignancy: A Systematic Review
- Application of metabolomics in the diagnosis of breast cancer: a systematic review
- Evaluation of aromatic amino acids as potential biomarkers in breast cancer by Raman spectroscopy analysis
- Review and Comparison of Cancer Biomarker Trends in Urine as a Basis for New Diagnostic Pathways
- Urinary Metabonomic Study on Colorectal Cancer
- Urinary Metabolites as Biomarkers for Diagnosis of Breast Cancer: A Preliminary Study
- Metabonomics studies on serum and urine of patients with breast cancer using 1 H-NMR spectroscopy
- Raman Spectroscopy Reveals Abnormal Changes in the Urine Composition of Prostate Cancer: An Application of an Intelligent Diagnostic Model with a Deep Learning Algorithm
- Detection of tyrosine and monitoring tyrosinase activity using an enzyme cascade-triggered colorimetric reaction
- Tyrosine crystals in urine